











Events & Presentations
| Upcoming Events |
| Details on upcoming events are not yet available. Please click here to be notified of all upcoming events. |
| Archived Events |
May 11, 2009
11:00 AM ET
|
Altus Pharmaceuticals First Quarter Results Conference Call
|
Mar 11, 2009
11:00 AM ET
|
Altus Pharmaceuticals Fourth Quarter Results Conference Call
|
Dec 3, 2008
11:00 AM
|
Piper Jaffray Health Care Conference
Speaker: Georges Gemayel, Chief Executive Officer, Altus Pharmaceuticals
|
Nov 4, 2008
11:00 AM ET
|
Altus Pharmaceuticals Third Quarter Results Conference Call
|
Jul 9, 2008
4:30 PM
|
Collins Stewart Growth Conference
|
Jun 25, 2008
8:30 AM ET
|
Jefferies 2nd Annual Healthcare Conference
|
Jun 24, 2008
7:00 AM ET
|
Piper Jaffray Europe Conference
|
May 7, 2008
11:00 AM ET
|
Altus Pharmaceuticals First Quarter Results Conference Call
|
May 1, 2008
2:20 PM ET
|
Morgan Stanley 2008 Global Healthcare Unplugged Conference
|
Mar 18, 2008
2:25 PM ET
|
Cowen and Company Health Care Conference
|
Jan 30, 2008
2:00 PM
|
2008 Wachovia Healthcare Conference
|
Nov 28, 2007
9:30 AM ET
|
Lazard Healthcare Conference
|
Nov 7, 2007
11:00 AM ET
|
Altus Pharmaceuticals Third Quarter Results Conference Call
|
Aug 8, 2007
11:00 AM ET
|
Altus Pharmaceuticals Second Quarter Results Conference Call
|
Jul 11, 2007
10:30 AM
|
Altus Pharmacueticals to present at: C.E. Unterberg, Towbin Emerging Growth Conference
Speaker: Sheldon Berkle, President and Chief Executive Officer
Mandarin Oriental Hotel New York City
|
|
May 23, 2007
|
The Citigroup 2007 Healthcare Conference
|
May 9, 2007
4:30 PM ET
|
Altus Pharmaceuticals First Quarter Results Conference Call
|
May 2, 2007
4:30 PM
|
Morgan Stanley Global Healthcare Unplugged Conference
|
Mar 14, 2007
10:15 AM ET
|
Cowen and Company Annual Health Care Conference
|
Mar 12, 2007
11:00 AM ET
|
Altus Pharmaceuticals Fourth Quarter and Year End Results Conference Call
|

= add file to Briefcase
© 2009 Altus Pharmaceuticals Inc. All Rights Reserved
| Terms and
Conditions | Privacy
Policy | Contact Us
This website contains certain
“forward-looking” statements. These statements are based on the
current estimates and assumptions of Altus Pharmaceuticals Inc. (“Altus” or “the Company”) as of the date of this presentation and are
subject to uncertainties and changes in circumstances. Given these uncertainties,
you should not place undue reliance on these forward-looking statements. Actual
results may vary materially from the expectations contained herein. When used
herein, the words “may”, “will”, “should”,
“could”, “would”, “plan”,
“anticipate”, “believe”, “estimate”,
“intend”, “project”, “potential” and
“expect” and similar expressions are intended to identify such
forward-looking statements. Such forward-looking statements are subject to
risks, uncertainties, assumptions and other factors that may cause the actual
results of Altus to be materially different from those reflected in such
forward-looking statements. Important factors that could cause actual results
to differ materially from those indicated by such forward-looking statements
include, among others, those set forth under the headings “Special Note
Regarding Forward-Looking Statements”, “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” in the Company's most recent annual or quarterly
filing with the Securities and Exchange Commission , as well as those set forth
in the Company's other filings with the Securities and Exchange Commission.
Except to the extent required by applicable securities laws, Altus is not under
any obligation to (and expressly disclaims any such obligation to) update its
forward-looking statements, whether as a result of new information, future
events, or otherwise. All statements or materials contained on a page of this
website are made only as of the date of revision set forth on that page.